Cases & Deals

GRA Venture Fund invests in Clearside Biomedical

Clients GRA Venture Fund, LLC

Jones Day represented GRA Venture Fund, LLC in connection with its purchase of Series A Convertible Preferred Stock in a private placement by Clearside Biomedical, Inc., an ophthalmic company specializing in the research, development, and commercialization of therapeutic products through a proprietary ocular microinjection platform that targets the individual compartments of the eye.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.